3-37025629-T-TTTTTTTTA
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP6_Moderate
The NM_000249.4(MLH1):c.1039-8_1039-7insTTTTTTTA variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000030 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000046 ( 1 hom. )
Consequence
MLH1
NM_000249.4 splice_region, splice_polypyrimidine_tract, intron
NM_000249.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0980
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP6
Variant 3-37025629-T-TTTTTTTTA is Benign according to our data. Variant chr3-37025629-T-TTTTTTTTA is described in ClinVar as [Benign]. Clinvar id is 215448.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLH1 | NM_000249.4 | c.1039-8_1039-7insTTTTTTTA | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000231790.8 | NP_000240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH1 | ENST00000231790.8 | c.1039-8_1039-7insTTTTTTTA | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000249.4 | ENSP00000231790 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000296 AC: 4AN: 135300Hom.: 0 Cov.: 19
GnomAD3 genomes
AF:
AC:
4
AN:
135300
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000462 AC: 51AN: 1103210Hom.: 1 Cov.: 20 AF XY: 0.0000367 AC XY: 20AN XY: 545208
GnomAD4 exome
AF:
AC:
51
AN:
1103210
Hom.:
Cov.:
20
AF XY:
AC XY:
20
AN XY:
545208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000296 AC: 4AN: 135290Hom.: 0 Cov.: 19 AF XY: 0.0000459 AC XY: 3AN XY: 65430
GnomAD4 genome
AF:
AC:
4
AN:
135290
Hom.:
Cov.:
19
AF XY:
AC XY:
3
AN XY:
65430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The MLH1 c.1039-8_1039-7insTTTTTA variant was not identified in the literature nor was it identified in dbSNP, COSMIC, Mismatch Repair Genes Variant Database, MMR Gene Unclassified Variants Database, InSiGHT Colon Cancer Gene Variant Database, Zhejiang Colon Cancer, COGR, or UMD databases. The variant was identified in the Clinvar database (classified as benign by Invitae). Clinvar also documents multiple variant deletions and insertions in this 5’ polynucleotide stretch as benign or likely benign. The variant was identified in control databases in 3079 of 118408 chromosomes (58 homozygous) at a frequency of 0.03, increasing the likelihood this could be a benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 524 of 5932 chromosomes (freq: 0.09), European (Non-Finnish) in 1791 of 58686 chromosomes (freq: 0.03), Other in 59 of 2174 chromosomes (freq: 0.03), East Asian in 121 of 5950 chromosomes (freq: 0.02), Finnish in 270 of 15534 chromosomes (freq: 0.02), Latino in 111 of 8698 chromosomes (freq: 0.01), South Asian in 157 of 16556 chromosomes (freq: 0.009), and Ashkenazi Jewish in 46 of 4878 chromosomes (freq: 0.009). In a study of Slovenian patients with gastric cancer, the variant IVS12 1039-7delT(n) is considered a germline polymorphism, co-occurring with pathogenic germline MLH1 mutation(s), detected in matched normal and tumour tissue of these patients (Hudler 2004). The variant occurs outside of the splicing consensus sequence and 2 out of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a greater than 10% difference in splicing; however, this information is not predictive enough to assume pathogenicity. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. - |
Hereditary nonpolyposis colorectal neoplasms Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at